FFR vs. Angiography: A Latest Standard in Heart Care

For patients facing coronary artery disease, determining the best course of treatment—whether it’s medication, angioplasty with stenting (PCI), or bypass surgery—is critical. Traditionally, doctors have relied on coronary angiography, an X-ray imaging procedure, to visualize blockages in the heart’s arteries. However, a more advanced technique, fractional flow reserve (FFR), is increasingly being used to provide a more precise assessment of the severity of these blockages and guide PCI decisions. This article explores the benefits of FFR, how it compares to angiography, and what the latest research reveals about its impact on patient outcomes.

Understanding Coronary Angiography and FFR

Coronary angiography involves injecting a contrast dye into the coronary arteries and taking X-ray images. While it effectively shows where blockages are located, it doesn’t always accurately determine how much blood flow is being restricted. This can lead to unnecessary stenting of non-problematic areas or, conversely, a failure to address significant blockages.

Fractional flow reserve (FFR), directly measures the pressure difference across a coronary artery stenosis (narrowing). A pressure wire is advanced through a catheter to the blocked artery. By measuring the pressure drop, FFR determines the functional significance of the blockage – essentially, how much it’s impacting blood flow to the heart muscle. An FFR value of 0.80 or less generally indicates a hemodynamically significant blockage that warrants intervention. ¹

FFR-Guided PCI: Improved Outcomes

Multiple studies have demonstrated that FFR-guided PCI leads to better clinical outcomes compared to angiography-guided PCI. A meta-analysis of randomized controlled trials focusing on patients with chronic coronary syndrome (CCS) or non-ST-elevation acute coronary syndromes (NSTE-ACS) showed that FFR-guided PCI was associated with reduced major adverse cardiac events (MACE), primarily due to fewer peri-procedural myocardial infarctions (MIs). ³

Specifically, the research revealed:

• A 20% reduction in the risk of MACE (all-cause death, MI, and repeat revascularization) with FFR guidance.
• A significant reduction in the risk of MI.
• No differences in mortality or MACE beyond 30 days.

patients undergoing FFR-guided PCI often require fewer stents and have fewer vessels treated compared to those guided by angiography alone. ³ This can translate to a lower risk of complications and a faster recovery.

Angiography-Derived FFR: A New Approach

Recent advancements have led to the development of angiography-derived FFR, which estimates FFR from standard coronary angiography images using computational fluid dynamics. This eliminates the need for a pressure wire and hyperaemic agents, offering a less invasive alternative while maintaining good correlation with invasive, wire-based FFR. ²

Long-Term Benefits Confirmed

The long-term benefits of FFR-guided PCI have been confirmed by the Fractional Flow Reserve versus Angiography for Multivessel Evaluation 2 (FAME 2) trial. At 11.2 years of follow-up, patients with stable coronary artery disease who underwent FFR-guided PCI experienced a reduced risk of death, myocardial infarction, or urgent revascularization compared to those managed with medical therapy alone. ⁴ The win ratio favored PCI, with a win difference of 5.9% (95% CI 0.2–11.6).

Key Takeaways

• FFR provides a more accurate assessment of coronary artery blockage severity than angiography alone.
• FFR-guided PCI is associated with improved clinical outcomes, including reduced MACE and MI rates.
• Angiography-derived FFR offers a less invasive alternative to traditional FFR.
• Long-term follow-up studies confirm the sustained benefits of FFR-guided PCI.

The Future of Coronary Intervention

As research continues to evolve, FFR is poised to become an increasingly integral part of the evaluation and treatment of coronary artery disease. The ability to precisely identify and address hemodynamically significant blockages will lead to more effective interventions, improved patient outcomes, and a more personalized approach to cardiac care.